XML 84 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration obligations [1] $ 2,710 $ 0
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other assets  
Fair value measurements, recurring [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swaps $ 31,870 7,160
Foreign currency forward contracts 247  
Total financial assets 32,117 7,160
Foreign currency forward contracts 323  
Contingent consideration obligations 2,710  
Total financial liabilities 3,033  
Fair value measurements, recurring [Member] | Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swaps 0 0
Foreign currency forward contracts 0  
Total financial assets 0 0
Foreign currency forward contracts 0  
Contingent consideration obligations 0  
Total financial liabilities 0  
Fair value measurements, recurring [Member] | Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swaps 31,870 7,160
Foreign currency forward contracts 247  
Total financial assets 32,117 7,160
Foreign currency forward contracts 323  
Contingent consideration obligations 0  
Total financial liabilities 323  
Fair value measurements, recurring [Member] | Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swaps 0 0
Foreign currency forward contracts 0  
Total financial assets 0 $ 0
Foreign currency forward contracts 0  
Contingent consideration obligations 2,710  
Total financial liabilities $ 2,710  
[1] See discussion of our acquisition of Kilter at Note 3 to these consolidated financial statements.